Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection

被引：69

作者：

Nicholls, AJ ^{[1
]}

机构：

[1] Roche Global Dev, Palo Alto, CA 94304 USA

来源：

关键词：

D O I：

10.1016/S0009-9120(98)00056-3

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：329 / 333

页数：5

共 10 条

[1] Bullingham RES, 1996, TRANSPLANT P, V28, P925
[2] GRINYO J, 1995, LANCET, V345, P1321
[3] *HOFFM ROCH INC, 1995, MYC MOF PRESCR INF
[4] Hosmer D., 1989, Applied Logistic Regression, V1st, DOI DOI 10.1097/00019514-200604000-00003
[5] Keown P, 1996, TRANSPLANTATION, V61, P1029
[6] THE RANDOMIZED CONCENTRATION-CONTROLLED TRIAL - AN EVALUATION OF ITS SAMPLE-SIZE EFFICIENCY
SANATHANAN, LP
PECK, CC
[J]. CONTROLLED CLINICAL TRIALS, 1991, 12 (06): : 780 - 794
[7] MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL-ALLOGRAFT RECIPIENTS
SOLLINGER, HW
[J]. TRANSPLANTATION, 1995, 60 (03) : 225 - 232
[8] TAKAHASHI K, 1995, TRANSPLANT P, V27, P1421
[9] Tsina I, 1996, J CHROMATOGR B, V675, P119
[10] Time-dependent effects of fixed covariates in Cox regression
Verweij, PJM
vanHouwelingen, HC
[J]. BIOMETRICS, 1995, 51 (04) : 1550 - 1556